RUA Life Sciences Stock Forecast for 2023 - 2025 - 2030

Updated on 04/27/2024

Stock Rating
0
Price Target
£0.66
Consensus
Upside
500.00%
Analysts
0
Stock Rating
0
Upside
500.00%
Analysts
0
Price Target
£0.66

RUA Life Sciences Stock Forecast and Price Target

RUA Life Sciences's stock is projected to advance by 500% from the previous closing price if it reaches the average target of £0.66 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of £1.06 and a low-end estimate of £0.25. If you are not interested in RUA stock, you may still be interested in its competitors and their current standings.

£0.66

500.00% Upside

RUA Life Sciences Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, RUA Life Sciences's Price has grown, increasing from £0.00 to £0.00 – a growth of 100.00%. The next year looks promising for RUA Life Sciences, with analysts predicting Fair Value of £0.12 – an increase of 100.00%. Over the next six years, experts anticipate that RUA Life Sciences's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
£0.12
2026 Fair Value Forecast
£0.13
2027 Fair Value Forecast
£0.14
2028 Fair Value Forecast
£0.16
2029 Fair Value Forecast
£0.17
2030 Fair Value Forecast
£0.19

RUA Life Sciences Revenue Forecast for 2023 - 2025 - 2030

In the last three years, RUA Life Sciences's Revenue has grown, increasing from £490.00k to £2.18M – a growth of 344.90%. For the next year, 0 analysts project RUA Life Sciences's Revenue to drop by 33.11%, reaching £1.46M. By 2030, professionals believe that RUA Life Sciences's Revenue will decrease by 23.89%, reaching £1.66M – a concerning trend for the company.

2024 Rev Forecast
£0.00B
2025 Rev Forecast
£0.00B
2026 Rev Forecast
£0.00B
2027 Rev Forecast
£0.00B
2028 Rev Forecast
£0.00B
2029 Rev Forecast
£0.00B
2030 Rev Forecast
£0.00B

RUA Life Sciences Dividend per Share Forecast for 2023 - 2025 - 2030

RUA Life Sciences Free Cash Flow Forecast for 2023 - 2025 - 2030

2025 FCF Forecast
£-800000.00
2026 FCF Forecast
£700.00k
2027 FCF Forecast
£-800030.00
2028 FCF Forecast
£-1228606.07
2029 FCF Forecast
£-976045.62
2030 FCF Forecast
£-1556792.76

RUA Life Sciences EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, RUA Life Sciences's EBITDA has grown by 150.00%, rising from £-780.00k to £-1.95M. According to 1 major analysts, RUA Life Sciences's EBITDA will fall by 56.41% in the next year, reaching £-850.00k. Professionals believe that By 2030, RUA Life Sciences's EBITDA will fall to £291.09k– a 114.93% decrease from its current value.

2025 EBITDA Forecast
£-850000.00
2026 EBITDA Forecast
£680.00k
2027 EBITDA Forecast
£473.80k
2028 EBITDA Forecast
£391.57k
2029 EBITDA Forecast
£182.10k
2030 EBITDA Forecast
£291.09k

RUA Life Sciences EBIT Forecast for 2023 - 2025 - 2030

In the last three years, RUA Life Sciences's EBIT has grown by 145.74%, rising from £-940.00k to £-2.31M. In the next year, 2 analysts estimate that RUA Life Sciences's EBIT will decrease by 49.78%, reaching £-1.16M. According to professional forecasts, in 2030, RUA Life Sciences's EBIT will decrease by 74.89%, reaching £-580.00k.

2025 EBIT Forecast
£-1160000.00
2026 EBIT Forecast
£330.00k
2027 EBIT Forecast
£-55715.00
2028 EBIT Forecast
£-118843.81
2029 EBIT Forecast
£-193184.57
2030 EBIT Forecast
£-580004.48

RUA Life Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, RUA Life Sciences's EPS has grown, increasing from £-0.08 to £0.00 – a growth of 100.00%. The next year looks promising for RUA Life Sciences, with analysts predicting EPS of £-0.02 – an increase of 100.00%. Over the next six years, experts anticipate that RUA Life Sciences's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
£-0.02
2026 EPS Forecast
£0.01
2027 EPS Forecast
£0.00
2028 EPS Forecast
£0.00
2029 EPS Forecast
£0.00
2030 EPS Forecast
£0.00